Joerg Reinhard, hasta ahora CEO en la unidad de vacunas de Novartis ha sido nombrado para un nuevo y más importante puesto en la organización.
Un nuevo puesto?
The executive shuffle puts a spotlight on Joerg Reinhardt, 52, a Novartis veteran who has been running the vaccines unit. Reinhardt, given a newly created post of chief operating officer, will take some day-to-day duties from Daniel Vasella, the company's 55-year-old chief executive, the Basel-based company said in a release today.
O manos ocultas lo han "impuesto"?
Reinhardt ``would be a great choice'' to succeed Vasella, said Karl Heinz Koch, an analyst at Helvea in Geneva. Ethos Foundation, a Swiss activist investor group, has pressured Vasella to give up one of his roles as CEO and chairman.
sin embargo...
Vasella and the board agreed to extend his contract until 2010, keeping his current pay, Novartis said today.
"Porsia", y dada su experiencia, que se vacune...
Tapado: (Méx) (Pol) potential candidate (with official support):
Entradas
No hay comentarios:
Publicar un comentario